article thumbnail

AI use in repurposing drugs for Covid-19

Drug Discovery World

Clinical trials revealed eight out of nine predictions were correct. In the months and years that followed our screens to rapidly identify repurposable treatments for Covid-19, we watched closely as our predictions made their way through clinical studies and into patients.

Drugs 59
article thumbnail

What to expect from drug discovery and development in 2023

Drug Discovery World

The modernisation of R&D models could be key to reducing spend on new drugs, a point that Deloitte makes about the need to transform the clinical trials process. At the height of the pandemic, DCTs were seen as a viable alternative to keeping the engines running on clinical trials when non-critical in-person care was paused.